Your browser doesn't support javascript.
loading
Evolution of CD8+ T Cell Receptor (TCR) Engineered Therapies for the Treatment of Cancer.
Sun, Yimo; Li, Fenge; Sonnemann, Heather; Jackson, Kyle R; Talukder, Amjad H; Katailiha, Arjun S; Lizee, Gregory.
Afiliação
  • Sun Y; Department of Melanoma, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
  • Li F; Department of Melanoma, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
  • Sonnemann H; Department of Melanoma, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
  • Jackson KR; Department of Melanoma, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
  • Talukder AH; Department of Melanoma, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
  • Katailiha AS; Department of Melanoma, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
  • Lizee G; Department of Melanoma, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Cells ; 10(9)2021 09 10.
Article em En | MEDLINE | ID: mdl-34572028
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Linfócitos T CD8-Positivos / Receptores de Antígenos Quiméricos / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Linfócitos T CD8-Positivos / Receptores de Antígenos Quiméricos / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article